| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1528-1157.1995.TB00482.X |
| P698 | PubMed publication ID | 7614918 |
| P2093 | author name string | Shankar SK | |
| Satishchandra P | |||
| Acharya JN | |||
| P2860 | cites work | Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation | Q34152888 |
| The cherry-red spot-myoclonus syndrome | Q40156522 | ||
| Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples | Q43967268 | ||
| Maternally inherited mitochondrial myopathy and myoclonic epilepsy. | Q50584350 | ||
| Classification of progressive myoclonus epilepsies and related disorders | Q58417281 | ||
| P433 | issue | 5 | |
| P921 | main subject | progressive myoclonus epilepsy | Q7248853 |
| P304 | page(s) | 429-434 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | Familial progressive myoclonus epilepsy: clinical and electrophysiologic observations. | |
| P478 | volume | 36 |
| Q42610658 | A shared haplotype indicates a founder event in Unverricht-Lundborg disease patients from Serbia |
| Q28271795 | Clinical picture of EPM1-Unverricht-Lundborg disease |
| Q41815403 | Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole |
| Q33596336 | Lafora disease: epidemiology, pathophysiology and management |
| Q34085650 | Lafora's disease: towards a clinical, pathologic, and molecular synthesis |
| Q46938722 | Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. |
| Q37301575 | Metabolic effects of AEDs: impact on body weight, lipids and glucose metabolism |
| Q36075070 | Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects |
| Q37769152 | Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects |
Search more.